EGF-induced expression of the STAT3 target gene HIF1α was abolished by cetuximab in HNSCC cells expressing wild-type EGFR under hypoxic conditions, but not in EGFRvIII-expressing HNSCC cells [102, 103]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.